Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Sitagliptin in Short Bowel Syndrome with Intestinal Failure
2014-001941-25Phase 2Terminated
- Sponsor
- Rigshospitalet
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sitagliptin in short bowel syndrome (SBS) and intestinal malabsorption, sponsored by Rigshospitalet. Primary endpoint: Faecal weight/diarrhea. Started Oct 2014; status: terminated.
02
Drugs
sitagliptin
03
Conditions
short bowel syndrome (SBS)intestinal malabsorption
Beyond the preview
Go deeper on 2014-001941-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001941-25.